Flavonoid-Based Smart Drug Delivery Systems in Cancer Therapy: New Hope for Precision Medicine

Abstract

Flavonoids are polyphenolic compounds that have powerful anticancer properties. Despite this, they are not suitable for treating cancer due to low solubility, instability, and bioavailability. To enhance their durability and bioavailability, it has been suggested that using delivery methods that include flavonoids to enhance their bioavailability may be a promising solution. Our analysis will focus on the most promising flavonoid-based delivery methods developed for anticancer medicines, particularly for cervical cancer. In addition to flavonoids' enormous therapeutic potential, delivery methods are critical to achieving positive results in cancer therapy. In addition to their anticancer properties, flavonoids are also polyphenolic compounds that occur naturally. However, these compounds are not suitable for treating cancer due to their insolubility, stability, and bioavailability. By adding flavonoids to delivery systems, the properties of flavonoids can be enhanced, resulting in higher bioavailability and durability Data obtained highlights flavonoids' great therapeutic potential as well as the importance of constructing good delivery mechanisms for cancer patients to achieve good outcomes. In conclusion, flavonoids may provide more efficient and individualized cancer treatment when incorporated into delivery systems. The adoption of flavonoid-based cervical cancer treatment methods could significantly improve the quality of life of millions of women. By encapsulating flavonoids in delivery systems, chemotherapy's adverse effects can be reduced, and patient outcomes may improve.